NIR light may identify breast cancer patients who will benefit most from chemotherapy

NIR light may identify breast cancer patients who will benefit most from chemotherapy 02/14/2018 12:28 PM EST A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings from a first pilot study of the new imaging system -- a noninvasive method of measuring blood flow dynamics in response to a single breath hold -- were published today in Radiology. Full story at http://engineering.columbia.edu/news/infrared-light-breast-cancer-chemotherapy Source Columbia University School of Engineering and Applied Science This is an NSF News From the Field item. Follow NSF:  This email was sent using GovDelivery Communications Cloud on behalf of: National Science Foundation Update · 2415 Eisenhower Avenue, Alexandria, VA 22314 · 703-292-5111